Mouse genetics: A tool to help unlock the mechanisms of glaucoma

Journal of Glaucoma

Volumn 8, Issue 6, 1999, Pages 400-412

  John, Simon W M ^a   Anderson, Michael G ^a   Smith, Richard S ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Animal models; Genetics; Glaucoma; Intraocular pressure; Mice

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GLAUCOMA; INTRAOCULAR PRESSURE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MICE;

EID: 0033278381     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Pennisi E. Academic sequencers challenge celera in a sprint to the finish. Science 1999;283:1822-1823.
2. Spencer WH. Glaucoma. In, Spencer WH (ed.): Ophthalmic Pathology: An Atlas and Textbook. Philadelphia: WB Saunders, 1996;438-512.
3. Ritch R, Shields MB, Krupin T (eds.). The Glaucomas: Clinical Science. Second edition, volume 2. St. Louis, MO: Mosby-Year Book, 1996.
4. Thylefors B, Negrel AD. The global impact of glaucoma. Bull WHO 1994;72:323-326.
5. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996;80:389-393.
6. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol 1983;118:166-191.
7. Drance SM. The early structural and functional disturbances of chronic open-angle glaucoma: the Robert N. Shaffer lecture. Ophthalmology 1985;92:853-857.
8. Ritch R, Shields MB, Krupin T. Chronic open-angle glaucoma: treatment overview. In, Ritch R, Shields MB, Krupin T (eds.): The Glaucomas: Glaucoma Therapy. St. Louis, MO: Mosby Year Book, 1996;1507-1519.
9. Hattenhauer MG, Johnson DH, Ing HH, Herman DB, Hodge DO, Yawn BP, et al. The probability of blindness from open-angle glaucoma. Ophthalmology 1998;105:2099-2104.
10. Jampel HD, Nickells R, Zack DJ. Glaucoma. In, Rimoin DL, Connor JM, Pyeritz RE (eds.): Principles and Practice of Medical Genetics. New York: Churchill Livingstone, 1996;2505-2521.
11. Evans K, Bird AC. The genetics of complex ophthalmic disorders. Br J Ophthalmol 1996;80:763-768.
12. Wiggs JL. Genetics of open-angle glaucoma. In, Traboulsi EI (ed.): Genetic Diseases of the Eye. New York: Oxford University Press, 1998;183-216.
13. Orr HT, Clark HB. Genetic approaches to pathogenesis of neurodegenerative diseases. Lab Invest 1995;73:161-171.
14. Gelatt KN, Brooks DE, Samuelson DA. Comparative Glaucomatology I the spontaneous glaucomas. J Glaucoma 1998;7:187-201.
15. Gelatt KN, Brooks DE, Samuelson DA. Comparative glaucomatology. II. The experimental glaucomas. J Glaucoma 1998;7: 282-294.
16. John SWM, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 1998;39:951-962.
17. Chang B, Smith RS, Hawes NL, Anderson MG, Zabaleta A, Savinova O. et al. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet 1999;21:405-409.
18. Paigen K. A miracle enough: the power of mice. Nature Med 1995;1:215-220.
19. Travis GH, Brennan MB, Danielson PE, Kozak CA, Sutcliffe JG. Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature 1989; 338:70-73.
20. Bowes C, Li T, Frankel WN, Danciger M, Coffin JM, Applebury ML, Farber DB. Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase. Proc Natl Acad Sci U S A 1993;90:2955-2959.
21. Pittler SJ, Baehr W. Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc Natl Acad Sci U S A 1991;88:8322-8326.
22. Weil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995;374:60-61.
23. Gibson F, Walsh J, Mburu P, Varela A, Brown KA, Antonio M, et al. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 1995;374:62-64.
24. Kajiwara K, Hahn LB, Mukai S, Travis GH, Berson EL, Dryja TP. Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature 1991;354:480-483.
25. McLaughlin ME, Sandberg MA, Berson EL, Dryja TP. Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat Genet 1993; 4:130-134.
26. Chang GQ, Hao Y, Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 1993;11:595-605.
27. Portera Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci U S A 1994;91:974-978.
28. Lolley RN, Rong H, Craft CM. Linkage of photoreceptor degeneration by apoptosis with inherited defect in phototransduction. Invest Ophthalmol Vis Sci 1994;35:358-362.
29. Schimenti J, Bucan M. Functional genomics in the mouse: phenotype-based mutagenesis screens. Genome Res 1998;8:698-710.
30. Silver LM. Mouse Genetics Concepts and Applications. New York: Oxford University Press, 1995.
31. Frankel WN. Taking stock of complex trait genetics in mice. Trends Genet 1995;11:471-477.
32. Smithies O, Maeda N. Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc Natl Acad Sci U S A 1995;92:5266-5272.
33. Taylor EW, Xu J, Jabs EW, Meyers DA. Linkage analysis of genetic disorders. Methods Mol Biol 1997;68:11-25.
34. Wirtz MK, Samples JR, Rust K, Lie J, Nordling L, Schilling K, et al. GLC1F, a new primary open-angle glaucoma locus, maps to 7q35-q36. Arch Ophthalmol 1999;117:237-241.
35. Raymond V. Molecular genetics of the glaucomas: mapping of the first five "GLC" loci. Am J Hum Genet 1997;60:272-277.
36. Sarfarazi M. Recent advances in molecular genetics of glaucomas. Hum Mol Genet 1997;6:1667-1677.
37. Andersen JS, Pralea AM, DelBono EA, Haines JL, Gorin MB, Schuman JS, et al. A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol 1997;115:384-388.
38. Stone EM, Alward WLM, Nguyen TD, Polansky JR, Funden SLF, Nishimura D, et al. Identification of a gene that causes primary open angle glaucoma. Science 1997;275:668-678.
39. Stoilov I, Nurten Akarsu A, Sarfarazi M. Identification of cytochrome P4501B1 as the gene mutated in primary congenital glaucoma families lined to the GLC3A locus on 2p21 [abstract]. Am J Hum Genet 1997;61:21.
40. Jordan T, Hanson I, Zaletayev D, Hodgson S, Prosser J, Seawright A, et al. The human PAX6 gene is mutated in two patients with aniridia. Nat Genet 1992;1:328-332.
41. Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson NA, et al. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 1996;14:392-399.
42. Nishimura DY, Swiderski RE, Alward WLM, Searby CC, Patil SR, Benner SR, et al. The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet 1998;19:140-147.
43. Mears AJ, Jordan T, Mirzayans F, Dubois S, Kume T. Parlee M, et al. Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet 1998; 63:1316-1328.
44. Orban PC, Chui D, Marth JD. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A 1992;89:6861-6865.
45. Porter A. Controlling your losses: conditional gene silencing in mammals. Trends Genet 1998;14:73-79.
46. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, Chambon P, Metzger D. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci U S A 1997;94:14559-14563.
47. Schwenk F, Kuhn R, Angrand PO, Rajewsky K, Stewart AF. Temporally and spatially regulated somatic mutagenesis in mice Nucleic Acids Res 1998;26:1427-1432.
48. Harding TC, Geddes BJ, Murphy D, Knight D, Uney JB. Switching transgene expression in the brain using an adenoviral tetracyclinc-regulatable system. Nat Biotech 1998;16:553-555.
49. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 1996;93:10933-10938.
50. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995;102:48-53.
51. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma: a population-based assessment. Arch Ophthalmol 1995;113:216-221.
52. Leske MC, Podgor MJ. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol 1983;118: 280-287.
53. Collins FS. Positional cloning moves from perditional to traditional. Nat Genet 1995;9:347-350.
54. Phillips PC. From complex traits to comples alleles. Trends Genet 1999;15:6-8.
55. Davis AP, Justice MJ. Mouse alleles: if you've seen one, you haven't seen them all. Trends Genet 1998;14:438-441.
56. John SWM, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995;267:679-681.
57. Sonnenberg H, Honrath U, Chong CK, Field LJ, Veress AT. Proximal tubular function in transgenic mice overexpressing atrial natriuretic factor. Can J Physiol Pharmacol 1994;72:1168-1170.
58. Barbee RW, Perry BD, Re RN, Murgo JP, Field LJ. Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor. Circ Res 1994;74:747-751.
59. Uchida H, Brigatti L, Caprioli J. Detection of structural damage from glaucoma with confocal laser image analysis. Invest Ophthalmol Vis Sci 1996;37:2393-2401.
60. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99:635-649.
61. Reme C, Urner U, Aeberhard B. The development of the chamber angle in the rat eye: morphological characteristics of developmental stages. Graefes Arch Clin Exp Ophthalmol 1983;220:139-153.
62. Morrison J, Farrell S, Johnson E, Deppmeier L, Moore CG, Grossman E. Structure and composition of the rodent lamina cribrosa. Exp Eye Res 1995;60:127-135.
63. McMenamin PG, Al-Shakarchi MJ. The effect of various levels of intraocular pressure on the rat aqueous outflow system. J Anat 1989;162:67-82.
64. van der Zypen E. Experimental morphological study on structure and function of the filtration angel of the rat eye. Ophthalmologica 1977;174:285-298.
65. Tripathi RC. Comparative physiology and anatomy of the aqueous outflow pathway. In, Davson H, Graham LTJ (eds.): The Eye. New York: Academic Press, 1974;163-356.
66. Smith RS, Bechtold L, John SWM. Ultrastructure of mouse trabecular meshwork [abstract]. Invest Opthalmol Vis Sci 1998;39: S705.
67. Tamm ER, Russel P, Piatigorsky J. Development and characterization of an immortal and differentiated murine trabecular meshwork cell line. Invest Ophthalmol Vis Sci 1999;40:1392-1402.
68. Tripathi RC, Tripathi BJ. The mechanism of aqueous outflow in lower mammals. Exp Eye Res 1972;14:73-79.
69. Johansson JO. Inhibition and recovery of retrograde axoplasmic transport in rat optic nerve during and after elevated IOP in vivo. Exp Eye Res 1988;46:223-227.
70. John SWM, Hagaman JR, MacTaggart TE, Peng L, Smithes O. Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci 1997;38:249-253.
71. Sheldon WG, Warbritton AR, Bucci TJ, Turturro A. Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab Anim Sci 1995;45:508-518.
72. Palm DE, Keil LC, Severs WB. Angiotensin, vasopressin, and atrial natriuretic peptide in the rat eye. Proc Soc Exp Biol Med 1994;206:392-395.
73. Coca Prados M, Escribano J, Ortego J. Differential gene expression in the human ciliary epithelium. Prog Retinal Eye Res 1999; 18:403-429.
74. Ballermann BJ, Zeidel ML. Atrial natriuretic hormone. In Seldin DW, Giebisch G (eds.): The Kidney. New York: Raven Press, 1992;1843-1884.
75. Stone RA, Glembotski CC. Immunoactive atrial natriuretic peptide in the rat eye: molecular forms in anterior uvea and retina. Biochem Biophys Res Commun 1986;134:1022-1028.
76. Quirion R, Dalpe M, De Lean A, Gutkowska J, Cantin M, Genest J. Atrial natriuretic factor binding sites in brain and related structures. Peptides 1984;5:1167-1172.
77. Korenfeld MS, Becker B. Atrial natriuretic peptides: effects on intraocular pressure, cGMP, and aqueous flow. Invest Ophthalmol Vis Sci 1989;30:2385-2392.
78. Wolfensberger TJ, Singer DR, Freegard T, Markandu ND, Buckley MG, MacGregor GA. Evidence for a new role of natriuretic peptides: control of intraocular pressure. Br J Ophthalmol 1994; 78:446-448.
79. Lehman NL, Chang AT, Nguyen TD, Polansky JR, Crook RB. Atrionatriuretic peptide receptors on human trabecular meshwork cells [abstract]. Invest Ophthalmol Vis Sci 1994;35:2053.
80. Chang AT, Polansky JR, Crook RB. Natriuretic peptide receptors on human trabecular meshwork cells. Curr Eye Res 1996;15:137-143.
81. Ritch R, Steinberger D, Liebmann JM. Prevalence of pigment dispersion syndrome in a population undergoing glaucoma screening. Am J Ophthalmol 1993;115:707-710.
82. Richter CU, Richardson TM, Grant WM. Pigmentary dispersion syndrome and pigmentary glaucoma: a prospective study of the natural history. Arch Ophthalmol 1986;104:211-215.
83. Migliazzo CV, Shaffer RN, Nykin R, Magee S. Long-term analysis of pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology 1986;93:1528-1536.
84. Farrar SM, Shields MB, Miller KN, Stoup CM. Risk factors for the development and severity of glaucoma in the pigment dispersion syndrome. Am J Ophthalmol 1989;108:223-229.
85. Jackson IJ. A cDNA encoding tyrosinase-related protein maps to the brown locus in mouse. Proc Natl Acad Sci U S A 1988;85: 4392-396.
86. Bennett DC, Huszar D, Laipis PJ, Jaenisch R, Jackson IJ. Phenotypic rescue of mutant brown melanocytes by a retrovirus carrying a wild-type tyrosinase-related protein gene. Development 1990;110:471-475.
87. Jackson IJ, Chambers DM, Tsukamoto K. Copeland NG, Gilbert DJ, Jenkins NA, Hearing V. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J 1992;11:527-535.
88. Zdarsky E, Favor J, Jackson IJ. The molecular basis of brown, an old mouse mutation, and of an induced revertant to wild type. Genetics 1990;126:443-49.
89. Shibahara S, Tomita Y, Yoshizawa M, Shibata K, Tagami H. Identification of mutations in the pigment cell-specific gene located at the brown locus in mouse. Pigment Cell Res 1992;2:90-95.
90. Johnson R, Jackson IJ. Light is a dominant mouse mutation resulting in premature cell death. Nat Genet 1992;1:226-229.
91. Brubaker RF. Delayed functional loss in glaucoma: the twelfth Edward Jackson memorial lecture. Am J Ophthalmol 1996;121: 473-483.
92. Nickells RW. Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J Glaucoma 1996;5:345-356.
93. Caprioli J. Avenues toward neuroprotection of the optic nerve in glaucoma. In, Bucci MG (ed.): Glaucoma Decision Making in Therapy. New York: Springer Verlag, 1996;323-329.
94. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995;36:774-786.
95. Garcia Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995;61:33-44.
96. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997;115:1031-1035.
97. Dreyer EB, Zurakowski D, Schumer RA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996;114:299-305.
98. Quigley HA. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol 1995;23:85-91.
99. Dreyer BA, Lipton SA. New perspective on glaucoma. JAMA 1999;281:306-308.
100. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993;75:1273-1286.
101. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-242.
102. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 1995;92:10688-10692.
103. Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol 1997;115:497-503.
104. Vorwerk CK, Hyman BT, Miller JW, Husain D, Zurakowski D, Huang PL, et al. The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity. Invest Ophthalmol Vis Sci 1997;38:2038-2044.
105. Ernfors P, Lee KF, Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 1994;368: 147-150.
106. Ernfors P, Kucera J, Lee K-F, Loring J, Jaenisch R. Studies on the physiological role of brain-derived neurotrophic factor and neurotrophin-3 in knockout mice. Int J Dev Biol 1995;39:799-807.
107. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993;75:229-240.
108. Knudson CM, Tung KS, Tourtellotte WG, Brown GA. Korsmeyer SJ. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995;270:96-99.
109. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Nakayama K, et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995;267: 1506-1510.
110. Li Y, Schlamp CL, Nickells RW. Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci 1999;40:1004-1008.
111. Cenni MC, Bonfanti L, Martinou JC, Ratto GM, Strettoi E, Maffei L. Long-term survival of retinal ganglion cells following optic nerve section in adult bcl-2 transgenic mice. Eur J Neurosci 1996;8:1735-1745.
112. Ramírez-Solis R, Liu P, Bradley A. Chromosome engineering in mice. Nature 1995;378:720-724.
113. Kubota R, Noda S, Wang Y, Minoshima S, Asakawa S, Kudoh J, et al. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics 1997;41:360-369.
114. Kubota R, Kudoh J, Mashima Y, Asakawa S. Minoshima S, Hejtmancik J, et al. Genomic organization of the human myocilin gene (MYOC) responsible for primary open angle glaucoma (GLC1A). Biochem Biophys Res Commun 1998;242:396-400.